| 1 |
Optimal Treatment of Non-Muscle Invasive Urothelial Carcinoma Including Perioperative Management Revisited |
|
| | Matthew J. Pagano,Gina Badalato,James M. McKiernan | | | Current Urology Reports. 2014; 15(11) | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Herbal medicines and nutritional supplements used in the treatment of glaucoma: A review |
|
| | Pathare, Y.S. and Wagh, V.D. | | | Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2012; 3(1): 331-339 | | | [Pubmed] [Google Scholar] | | | 3 |
CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa |
|
| | Palmeira, C., Lameiras, C., Amaro, T., Lima, L., Koch, A., Lopes, C., Oliveira, P.A., Santos, L. | | | Urologic Oncology: Seminars and Original Investigations. 2011; 29(2): 205-211 | | | [Pubmed] [Google Scholar] | | | 4 |
CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa |
|
| | Carlos Palmeira,Catarina Lameiras,Teresina Amaro,Luís Lima,Alberto Koch,Carlos Lopes,Paula A. Oliveira,Lúcio Santos | | | Urologic Oncology: Seminars and Original Investigations. 2011; 29(2): 205 | | | [Pubmed] [Google Scholar] [DOI] | |
|
